Tapewire

Nasdaq · USD

VRTX

VERTEX PHARMACEUTICALS INC / MA

Export transactions ↓
Tapewire entity
2875
SEC CIK
0000875320
Parsed reports
2,554

Last 12 months

Inside the activity.

0 purchase rows · 93 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202506
Dec 2025016
Jan 202602
Feb 2026049
Mar 202605
Apr 202601
May 202606
Jun 202605
Jul 202603
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 03, 2020 Filed Feb 5, 2020 21:51 UTC
Sachdev AmitEVP, Chief Patient Officer
Exercise / conversionCommon Stock 2,156 $91.05 $196,303.80
Disclosure

SEC source: 0001209191-20-006956 · doc4.xml · nonDerivative · entry 1

Sachdev Amit · CIK 0001406338 · EVP, Chief Patient Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,346

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 03, 2020 Filed Feb 5, 2020 21:52 UTC
Silva Paul MSVP & Controller
Exercise / conversionStock Option (Right to Buy) · Derivative 809 $0.00 Strike: $86.52 $0.00
Disclosure

SEC source: 0001209191-20-006959 · doc4.xml · derivative · entry 10

Silva Paul M · CIK 0001446372 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,236

Underlying: Common Stock · 809 shares

Expires 2027-02-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/03/2017.

Read SEC document
February 03, 2020 Filed Feb 5, 2020 21:52 UTC
Silva Paul MSVP & Controller
Exercise / conversionStock Option (Right to Buy) · Derivative 1,290 $0.00 Strike: $91.05 $0.00
Disclosure

SEC source: 0001209191-20-006959 · doc4.xml · derivative · entry 9

Silva Paul M · CIK 0001446372 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,290 shares

Expires 2026-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: Fully vested.

Read SEC document
February 03, 2020 Filed Feb 5, 2020 21:52 UTC
Silva Paul MSVP & Controller
SaleCommon Stock 210 $232.75 $48,877.50
Disclosure

SEC source: 0001209191-20-006959 · doc4.xml · nonDerivative · entry 7

Silva Paul M · CIK 0001446372 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,759

F1 · kind: Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.

F3 · price: Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F6 · price: Open market sales reported on this line occurred at a weighted average price of $232.75 (range $232.26 to $233.21).

Read SEC document
February 03, 2020 Filed Feb 5, 2020 21:52 UTC
Silva Paul MSVP & Controller
SaleCommon Stock 630 $231.46 $145,819.80
Disclosure

SEC source: 0001209191-20-006959 · doc4.xml · nonDerivative · entry 6

Silva Paul M · CIK 0001446372 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,969

F1 · kind: Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.

F3 · price: Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F5 · price: Open market sales reported on this line occurred at a weighted average price of $231.46 (range $231.21 to $231.63).

Read SEC document
February 03, 2020 Filed Feb 5, 2020 21:52 UTC
Silva Paul MSVP & Controller
SaleCommon Stock 809 $231.03 $186,903.27
Disclosure

SEC source: 0001209191-20-006959 · doc4.xml · nonDerivative · entry 5

Silva Paul M · CIK 0001446372 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,599

F1 · kind: Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.

Read SEC document
February 03, 2020 Filed Feb 5, 2020 21:52 UTC
Silva Paul MSVP & Controller
SaleCommon Stock 240 $230.28 $55,267.20
Disclosure

SEC source: 0001209191-20-006959 · doc4.xml · nonDerivative · entry 4

Silva Paul M · CIK 0001446372 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,408

F1 · kind: Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.

F3 · price: Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4 · price: Open market sales reported on this line occurred at a weighted average price of $230.28 (range $229.92 to $230.53).

Read SEC document
February 03, 2020 Filed Feb 5, 2020 21:52 UTC
Silva Paul MSVP & Controller
SaleCommon Stock 210 $228.91 $48,071.10
Disclosure

SEC source: 0001209191-20-006959 · doc4.xml · nonDerivative · entry 3

Silva Paul M · CIK 0001446372 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,648

F1 · kind: Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.

F2 · price: Open market sales reported on this line occurred at a weighted average price of $228.91 (range $228.37 to $229.24).

F3 · price: Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

Read SEC document
February 03, 2020 Filed Feb 5, 2020 21:52 UTC
Silva Paul MSVP & Controller
Exercise / conversionCommon Stock 809 $86.52 $69,994.68
Disclosure

SEC source: 0001209191-20-006959 · doc4.xml · nonDerivative · entry 2

Silva Paul M · CIK 0001446372 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,858

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 03, 2020 Filed Feb 5, 2020 21:52 UTC
Silva Paul MSVP & Controller
Exercise / conversionCommon Stock 1,290 $91.05 $117,454.50
Disclosure

SEC source: 0001209191-20-006959 · doc4.xml · nonDerivative · entry 1

Silva Paul M · CIK 0001446372 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,049

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 31, 2020 Filed Feb 4, 2020 21:10 UTC
Arbuckle Stuart AEVP, Chief Commercial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 4,692 $0.00 Strike: $187.53 $0.00
Disclosure

SEC source: 0001209191-20-006279 · doc4.xml · derivative · entry 11

Arbuckle Stuart A · CIK 0001557290 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,334

Underlying: Common Stock · 4,692 shares

Expires 2029-02-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/06/2019.

Read SEC document
January 31, 2020 Filed Feb 4, 2020 21:10 UTC
Arbuckle Stuart AEVP, Chief Commercial Officer
SaleCommon Stock 4,692 $238.65 $1,119,745.80
Disclosure

SEC source: 0001209191-20-006279 · doc4.xml · nonDerivative · entry 2

Arbuckle Stuart A · CIK 0001557290 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,240

F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1.

Read SEC document
January 31, 2020 Filed Feb 4, 2020 21:10 UTC
Arbuckle Stuart AEVP, Chief Commercial Officer
Exercise / conversionCommon Stock 4,692 $187.53 $879,890.76
Disclosure

SEC source: 0001209191-20-006279 · doc4.xml · nonDerivative · entry 1

Arbuckle Stuart A · CIK 0001557290 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,932

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 31, 2020 Filed Feb 4, 2020 21:11 UTC
Lee YuchunDirector
SaleCommon Stock 200 $233.37 $46,674.00
Disclosure

SEC source: 0001209191-20-006284 · doc4.xml · nonDerivative · entry 7

Lee Yuchun · CIK 0001334365 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,847

F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1.

F3 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F8 · price: Open market sales reported on this line occurred at a weighted average price of $233.37 (range $233.12 to $233.61).

Read SEC document
January 31, 2020 Filed Feb 4, 2020 21:11 UTC
Lee YuchunDirector
SaleCommon Stock 300 $232.51 $69,753.00
Disclosure

SEC source: 0001209191-20-006284 · doc4.xml · nonDerivative · entry 6

Lee Yuchun · CIK 0001334365 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,047

F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1.

F3 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F7 · price: Open market sales reported on this line occurred at a weighted average price of $232.51 (range $231.93 to $232.90).

Read SEC document
January 31, 2020 Filed Feb 4, 2020 21:11 UTC
Lee YuchunDirector
SaleCommon Stock 100 $230.04 $23,004.00
Disclosure

SEC source: 0001209191-20-006284 · doc4.xml · nonDerivative · entry 5

Lee Yuchun · CIK 0001334365 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,347

F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1.

Read SEC document
January 31, 2020 Filed Feb 4, 2020 21:11 UTC
Lee YuchunDirector
SaleCommon Stock 171 $227.54 $38,909.34
Disclosure

SEC source: 0001209191-20-006284 · doc4.xml · nonDerivative · entry 4

Lee Yuchun · CIK 0001334365 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,447

F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1.

F3 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F6 · price: Open market sales reported on this line occurred at a weighted average price of $227.54 (range $227.41 to $227.63).

Read SEC document
January 31, 2020 Filed Feb 4, 2020 21:11 UTC
Lee YuchunDirector
SaleCommon Stock 823 $226.64 $186,524.72
Disclosure

SEC source: 0001209191-20-006284 · doc4.xml · nonDerivative · entry 3

Lee Yuchun · CIK 0001334365 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,618

F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1.

F3 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F5 · price: Open market sales reported on this line occurred at a weighted average price of $226.64 (range $226.21 to $227.16).

Read SEC document
January 31, 2020 Filed Feb 4, 2020 21:11 UTC
Lee YuchunDirector
SaleCommon Stock 206 $225.10 $46,370.60
Disclosure

SEC source: 0001209191-20-006284 · doc4.xml · nonDerivative · entry 2

Lee Yuchun · CIK 0001334365 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,441

F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1.

F3 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4 · price: Open market sales reported on this line occurred at a weighted average price of $225.10 (range $225.03 to $225.46).

Read SEC document
January 31, 2020 Filed Feb 4, 2020 21:11 UTC
Lee YuchunDirector
SaleCommon Stock 200 $224.03 $44,806.00
Disclosure

SEC source: 0001209191-20-006284 · doc4.xml · nonDerivative · entry 1

Lee Yuchun · CIK 0001334365 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,647

F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1.

F2 · price: Open market sales reported on this line occurred at a weighted average price of $224.03 (range $223.64 to $224.42).

F3 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

Read SEC document
January 31, 2020 Filed Feb 4, 2020 21:13 UTC
Parini MichaelEVP, CL&AO
Exercise / conversionStock Option (Right to Buy) · Derivative 3,909 $0.00 Strike: $187.53 $0.00
Disclosure

SEC source: 0001209191-20-006289 · doc4.xml · derivative · entry 10

Parini Michael · CIK 0001661567 · EVP, CL&AO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,945

Underlying: Common Stock · 3,909 shares

Expires 2029-02-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/06/2019.

Read SEC document
January 31, 2020 Filed Feb 4, 2020 21:13 UTC
Parini MichaelEVP, CL&AO
Tax withholdingCommon Stock 1,344 $231.21 $310,746.24
Disclosure

SEC source: 0001209191-20-006289 · doc4.xml · nonDerivative · entry 3

Parini Michael · CIK 0001661567 · EVP, CL&AO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,659

Read SEC document
January 31, 2020 Filed Feb 4, 2020 21:13 UTC
Parini MichaelEVP, CL&AO
SaleCommon Stock 3,909 $238.65 $932,882.85
Disclosure

SEC source: 0001209191-20-006289 · doc4.xml · nonDerivative · entry 2

Parini Michael · CIK 0001661567 · EVP, CL&AO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,003

F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.

Read SEC document
January 31, 2020 Filed Feb 4, 2020 21:13 UTC
Parini MichaelEVP, CL&AO
Exercise / conversionCommon Stock 3,909 $187.53 $733,054.77
Disclosure

SEC source: 0001209191-20-006289 · doc4.xml · nonDerivative · entry 1

Parini Michael · CIK 0001661567 · EVP, CL&AO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,912

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 31, 2020 Filed Feb 4, 2020 21:15 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 20,000 $0.00 Strike: $53.85 $0.00
Disclosure

SEC source: 0001209191-20-006298 · doc4.xml · derivative · entry 14

SACHS BRUCE I · CIK 0001197036 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,000 shares

Expires 2021-05-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F14 · derivative.exercise_date: Fully vested.

Read SEC document
January 31, 2020 Filed Feb 4, 2020 21:15 UTC SaleCommon Stock 100 $235.40 $23,540.00
Disclosure

SEC source: 0001209191-20-006298 · doc4.xml · nonDerivative · entry 13

SACHS BRUCE I · CIK 0001197036 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,210

F1 · kind: Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1.

Read SEC document
January 31, 2020 Filed Feb 4, 2020 21:15 UTC SaleCommon Stock 900 $234.15 $210,735.00
Disclosure

SEC source: 0001209191-20-006298 · doc4.xml · nonDerivative · entry 12

SACHS BRUCE I · CIK 0001197036 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,310

F1 · kind: Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1.

F3 · price: Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F13 · price: Open market sales reported on this line occurred at a weighted average price of $234.15 (range $233.77 to $234.66).

Read SEC document
January 31, 2020 Filed Feb 4, 2020 21:15 UTC SaleCommon Stock 1,800 $233.13 $419,634.00
Disclosure

SEC source: 0001209191-20-006298 · doc4.xml · nonDerivative · entry 11

SACHS BRUCE I · CIK 0001197036 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,210

F1 · kind: Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1.

F3 · price: Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F12 · price: Open market sales reported on this line occurred at a weighted average price of $233.13 (range $232.69 to $233.49).

Read SEC document
January 31, 2020 Filed Feb 4, 2020 21:15 UTC SaleCommon Stock 1,200 $232.04 $278,448.00
Disclosure

SEC source: 0001209191-20-006298 · doc4.xml · nonDerivative · entry 10

SACHS BRUCE I · CIK 0001197036 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,010

F1 · kind: Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1.

F3 · price: Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F11 · price: Open market sales reported on this line occurred at a weighted average price of $232.04 (range $231.45 to $232.42).

Read SEC document
January 31, 2020 Filed Feb 4, 2020 21:15 UTC SaleCommon Stock 1,200 $230.87 $277,044.00
Disclosure

SEC source: 0001209191-20-006298 · doc4.xml · nonDerivative · entry 9

SACHS BRUCE I · CIK 0001197036 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,210

F1 · kind: Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1.

F3 · price: Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F10 · price: Open market sales reported on this line occurred at a weighted average price of $230.87 (range $230.32 to $231.23).

Read SEC document
January 31, 2020 Filed Feb 4, 2020 21:15 UTC SaleCommon Stock 500 $229.90 $114,950.00
Disclosure

SEC source: 0001209191-20-006298 · doc4.xml · nonDerivative · entry 8

SACHS BRUCE I · CIK 0001197036 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,410

F1 · kind: Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1.

F3 · price: Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F9 · price: Open market sales reported on this line occurred at a weighted average price of $229.90 (range $229.16 to $230.12).

Read SEC document
January 31, 2020 Filed Feb 4, 2020 21:15 UTC SaleCommon Stock 600 $228.33 $136,998.00
Disclosure

SEC source: 0001209191-20-006298 · doc4.xml · nonDerivative · entry 7

SACHS BRUCE I · CIK 0001197036 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,910

F1 · kind: Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1.

F3 · price: Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F8 · price: Open market sales reported on this line occurred at a weighted average price of $228.33 (range $227.97 to $228.78).

Read SEC document
January 31, 2020 Filed Feb 4, 2020 21:15 UTC SaleCommon Stock 300 $227.66 $68,298.00
Disclosure

SEC source: 0001209191-20-006298 · doc4.xml · nonDerivative · entry 6

SACHS BRUCE I · CIK 0001197036 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,510

F1 · kind: Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1.

F3 · price: Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F7 · price: Open market sales reported on this line occurred at a weighted average price of $227.66 (range $227.62 to $227.70).

Read SEC document
January 31, 2020 Filed Feb 4, 2020 21:15 UTC SaleCommon Stock 5,644 $227.01 $1,281,244.44
Disclosure

SEC source: 0001209191-20-006298 · doc4.xml · nonDerivative · entry 5

SACHS BRUCE I · CIK 0001197036 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,810

F1 · kind: Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1.

F3 · price: Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F6 · price: Open market sales reported on this line occurred at a weighted average price of $227.01 (range $226.70 to $227.59).

Read SEC document
January 31, 2020 Filed Feb 4, 2020 21:15 UTC SaleCommon Stock 4,198 $226.32 $950,091.36
Disclosure

SEC source: 0001209191-20-006298 · doc4.xml · nonDerivative · entry 4

SACHS BRUCE I · CIK 0001197036 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,454

F1 · kind: Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1.

F3 · price: Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F5 · price: Open market sales reported on this line occurred at a weighted average price of $226.32 (range $225.62 to $226.60).

Read SEC document
January 31, 2020 Filed Feb 4, 2020 21:15 UTC SaleCommon Stock 1,858 $224.98 $418,012.84
Disclosure

SEC source: 0001209191-20-006298 · doc4.xml · nonDerivative · entry 3

SACHS BRUCE I · CIK 0001197036 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,652

F1 · kind: Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1.

F3 · price: Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4 · price: Open market sales reported on this line occurred at a weighted average price of $224.98 (range $224.66 to $225.21).

Read SEC document
January 31, 2020 Filed Feb 4, 2020 21:15 UTC SaleCommon Stock 1,700 $224.02 $380,834.00
Disclosure

SEC source: 0001209191-20-006298 · doc4.xml · nonDerivative · entry 2

SACHS BRUCE I · CIK 0001197036 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,510

F1 · kind: Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1.

F2 · price: Open market sales reported on this line occurred at a weighted average price of $224.02 (range $223.58 to $224.40).

F3 · price: Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

Read SEC document
January 31, 2020 Filed Feb 4, 2020 21:15 UTC Exercise / conversionCommon Stock 20,000 $53.85 $1,077,000.00
Disclosure

SEC source: 0001209191-20-006298 · doc4.xml · nonDerivative · entry 1

SACHS BRUCE I · CIK 0001197036 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,210

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 31, 2020 Filed Feb 4, 2020 21:17 UTC
Silva Paul MSVP & Controller
Exercise / conversionStock Option (Right to Buy) · Derivative 1,396 $0.00 Strike: $187.53 $0.00
Disclosure

SEC source: 0001209191-20-006304 · doc4.xml · derivative · entry 4

Silva Paul M · CIK 0001446372 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,053

Underlying: Common Stock · 1,396 shares

Expires 2029-02-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/06/2019.

Read SEC document
January 31, 2020 Filed Feb 4, 2020 21:17 UTC
Silva Paul MSVP & Controller
SaleCommon Stock 1,396 $238.65 $333,155.40
Disclosure

SEC source: 0001209191-20-006304 · doc4.xml · nonDerivative · entry 2

Silva Paul M · CIK 0001446372 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,759

F1 · kind: Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.

Read SEC document
January 31, 2020 Filed Feb 4, 2020 21:17 UTC
Silva Paul MSVP & Controller
Exercise / conversionCommon Stock 1,396 $187.53 $261,791.88
Disclosure

SEC source: 0001209191-20-006304 · doc4.xml · nonDerivative · entry 1

Silva Paul M · CIK 0001446372 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,155

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 22, 2020 Filed Jan 24, 2020 21:10 UTC
Parini MichaelEVP, CL&AO
Exercise / conversionStock Option (Right to Buy) · Derivative 1 $0.00 Strike: $187.53 $0.00
Disclosure

SEC source: 0001209191-20-004809 · doc4.xml · derivative · entry 3

Parini Michael · CIK 0001661567 · EVP, CL&AO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,854

Underlying: Common Stock · 1 shares

Expires 2029-02-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vests in 16 quarterly installments from 02/06/2019.

Read SEC document
January 22, 2020 Filed Jan 24, 2020 21:10 UTC
Parini MichaelEVP, CL&AO
SaleCommon Stock 1 $237.50 $237.50
Disclosure

SEC source: 0001209191-20-004809 · doc4.xml · nonDerivative · entry 2

Parini Michael · CIK 0001661567 · EVP, CL&AO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,003

F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.

Read SEC document
January 22, 2020 Filed Jan 24, 2020 21:10 UTC
Parini MichaelEVP, CL&AO
Exercise / conversionCommon Stock 1 $187.53 $187.53
Disclosure

SEC source: 0001209191-20-004809 · doc4.xml · nonDerivative · entry 1

Parini Michael · CIK 0001661567 · EVP, CL&AO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,004

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 16, 2020 Filed Jan 21, 2020 21:14 UTC
Sachdev AmitEVP, Chief Patient Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $109.14 $0.00
Disclosure

SEC source: 0001209191-20-004251 · doc4.xml · derivative · entry 5

Sachdev Amit · CIK 0001406338 · EVP, Chief Patient Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,500

Underlying: Common Stock · 5,000 shares

Expires 2025-02-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Fully vested.

Read SEC document
January 16, 2020 Filed Jan 21, 2020 21:14 UTC
Sachdev AmitEVP, Chief Patient Officer
SaleCommon Stock 5,000 $235.00 $1,175,000.00
Disclosure

SEC source: 0001209191-20-004251 · doc4.xml · nonDerivative · entry 2

Sachdev Amit · CIK 0001406338 · EVP, Chief Patient Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,190

F1 · kind: Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1.

Read SEC document
January 16, 2020 Filed Jan 21, 2020 21:14 UTC
Sachdev AmitEVP, Chief Patient Officer
Exercise / conversionCommon Stock 5,000 $109.14 $545,700.00
Disclosure

SEC source: 0001209191-20-004251 · doc4.xml · nonDerivative · entry 1

Sachdev Amit · CIK 0001406338 · EVP, Chief Patient Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,190

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 15, 2020 Filed Jan 17, 2020 21:13 UTC GrantDeferred Stock Units · Derivative 199.741 $231.55 $46,250.03
Disclosure

SEC source: 0001209191-20-003955 · doc4.xml · derivative · entry 1

SACHS BRUCE I · CIK 0001197036 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,098.557

Underlying: Common Stock · 199.741 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death.

F1 · derivative.exercise_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death.

F1 · derivative.expiration_date: Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death.

Read SEC document
January 13, 2020 Filed Jan 15, 2020 21:08 UTC
Parini MichaelEVP, CL&AO
Exercise / conversionStock Option (Right to Buy) · Derivative 2,125 $0.00 Strike: $90.29 $0.00
Disclosure

SEC source: 0001209191-20-003457 · doc4.xml · derivative · entry 6

Parini Michael · CIK 0001661567 · EVP, CL&AO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,250

Underlying: Common Stock · 2,125 shares

Expires 2026-07-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: The option vests in 16 quarterly installments from 07/12/2016.

Read SEC document
January 13, 2020 Filed Jan 15, 2020 21:08 UTC
Parini MichaelEVP, CL&AO
SaleCommon Stock 300 $228.99 $68,697.00
Disclosure

SEC source: 0001209191-20-003457 · doc4.xml · nonDerivative · entry 5

Parini Michael · CIK 0001661567 · EVP, CL&AO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,003

F1 · kind: Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.

F3 · price: Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F6 · price: Open market sales reported on this line occurred at a weighted average price of $228.99 (range $228.79 to $229.27).

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.